PROLIXIN DECANOATE
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Jun 1972
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 14h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PROLIXIN DECANOATE is a long-acting depot injection formulation of fluphenazine decanoate, a typical antipsychotic. It is indicated for maintenance treatment of schizophrenia and other psychotic disorders in patients requiring prolonged antipsychotic therapy. The drug works by blocking dopamine receptors in the central nervous system, reducing psychotic symptoms.
LOE Approaching
As an established therapy approaching LOE with moderate competitive pressure (30), this product operates a mature maintenance franchise with likely stable but smaller commercial teams.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PROLIXIN DECANOATE offers limited career growth given its LOE-approaching status and minimal linked job openings (0 roles). Positions on this product are typically mature, focused on defensive market maintenance and stakeholder management rather than innovation or expansion.
Brand ManagerField Sales Representative
Worked on PROLIXIN DECANOATE at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.